comparemela.com

Latest Breaking News On - Department of cancer medicine - Page 1 : comparemela.com

Trastuzumab Deruxtecan Demonstrates Efficacy Reducing Brain Metastases in HER2m NSCLC

Regardless of presence of brain metastases, patients with HER2-mutant (HER2m) non–small cell lung cancer (NSCLC) showed systemic responses to trastuzumab deruxtecan. In addition, the therapy showed intracranial efficacy to reduce the size of brain metastases.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.